The Valley Desk

ArticleJournal for immunotherapy of cancerPublished

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal for immunotherapy of cancer
Published
Subject terms
CD8-Positive T-Lymphocytes; Lymphocytes, Tumor-Infiltrating; Cell Line, Tumor; Animals; Humans; Mice; Antineoplastic Combined Chemotherapy Protocols; Antigens, CD; Female; Immune Checkpoint Inhibitors; Lymphocyte Activation Gene 3 Protein; T-lymphocytes
PubMed ID
39343508
PubMed Central ID
PMC11440230
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal